News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
812,557 Results
Type
Article (63922)
Company Profile (412)
Press Release (748203)
Multimedia
Podcasts (181)
Webinars (27)
Section
Business (221280)
Career Advice (3377)
Deals (38029)
Drug Delivery (170)
Drug Development (87698)
Employer Resources (202)
FDA (17810)
Job Trends (16513)
News (376114)
Policy (36561)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (3026)
Academic (2)
Accelerated approval (55)
Adcomms (39)
Allergies (190)
Alliances (54618)
ALS (233)
Alzheimer's disease (1949)
Antibody-drug conjugate (ADC) (539)
Approvals (18151)
Artificial intelligence (794)
Autoimmune disease (342)
Automation (60)
Bankruptcy (394)
Best Places to Work (12378)
BIOSECURE Act (21)
Biosimilars (244)
Biotechnology (263)
Bladder cancer (210)
Brain cancer (82)
Breast cancer (827)
Cancer (6448)
Cardiovascular disease (533)
Career advice (2891)
Career pathing (52)
CAR-T (380)
CDC (74)
Celiac Disease (3)
Cell therapy (1027)
Cervical cancer (53)
Clinical research (75707)
Collaboration (2311)
Company closure (7)
Compensation (1482)
Complete response letters (100)
COVID-19 (3013)
CRISPR (123)
C-suite (1260)
Cystic fibrosis (164)
Data (8552)
Decentralized trials (3)
Denatured (61)
Depression (188)
Dermatology (96)
Diabetes (650)
Diagnostics (7516)
Digital health (63)
Diversity (14)
Diversity, equity & inclusion (48)
Drug discovery (377)
Drug pricing (237)
Drug shortages (37)
Duchenne muscular dystrophy (315)
Earnings (95889)
Editorial (78)
Employer branding (25)
Employer resources (172)
Events (131364)
Executive appointments (1182)
FDA (21793)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1891)
Gene editing (266)
Generative AI (72)
Gene therapy (819)
GLP-1 (1223)
Government (5401)
Grass and pollen (8)
Guidances (418)
Healthcare (20836)
HIV (90)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (114)
Immunology and inflammation (340)
Immuno-oncology (114)
Indications (201)
Infectious disease (3400)
Inflammatory bowel disease (238)
Inflation Reduction Act (17)
Influenza (145)
Intellectual property (313)
Interviews (653)
IPO (17399)
IRA (61)
Job creations (4463)
Job search strategy (2327)
JPM (71)
Kidney cancer (22)
Labor market (116)
Layoffs (657)
Leadership (53)
Legal (9017)
Liver cancer (110)
Longevity (35)
Lung cancer (862)
Lymphoma (460)
Machine learning (63)
Management (66)
Manufacturing (1164)
MASH (221)
Medical device (14974)
Medtech (15122)
Mergers & acquisitions (21905)
Metabolic disorders (1714)
mRNA (259)
Multiple sclerosis (203)
NASH (24)
Neurodegenerative disease (489)
Neuropsychiatric disorders (124)
Neuroscience (3644)
Neurotech (1)
NextGen: Class of 2026 (7388)
Non-profit (5039)
Now hiring (80)
Obesity (813)
Opinion (368)
Ovarian cancer (241)
Pain (277)
Pancreatic cancer (340)
Parkinson's disease (406)
Partnered (35)
Patents (639)
Patient recruitment (732)
Peanut (69)
People (65681)
Pharmaceutical (78)
Pharmacy benefit managers (36)
Phase 1 (23584)
Phase 2 (33150)
Phase 3 (24763)
Pipeline (9555)
Policy (385)
Postmarket research (3030)
Preclinical (10340)
Press Release (72)
Prostate cancer (339)
Psychedelics (68)
Radiopharmaceuticals (368)
Rare diseases (1221)
Real estate (6772)
Recruiting (80)
Regulatory (28113)
Reports (72)
Research institute (2723)
Resumes & cover letters (541)
Rett syndrome (40)
RNA editing (28)
RSV (96)
Schizophrenia (193)
Series A (322)
Series B (229)
Service/supplier (17)
Sickle cell disease (127)
Special edition (31)
Spinal muscular atrophy (183)
Sponsored (51)
Startups (4121)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (101)
The Weekly (117)
Vaccines (1272)
Venture capital (129)
Weight loss (550)
Women's health (135)
Worklife (24)
Date
Today (88)
Last 7 days (765)
Last 30 days (3412)
Last 365 days (32162)
2026 (15256)
2025 (32133)
2024 (37254)
2023 (42177)
2022 (53440)
2021 (58132)
2020 (57028)
2019 (50498)
2018 (38327)
2017 (35451)
2016 (35635)
2015 (41767)
2014 (35759)
2013 (31297)
2012 (33430)
2011 (33932)
2010 (32581)
Location
Africa (1036)
Alabama (97)
Alaska (7)
Arizona (387)
Arkansas (16)
Asia (46473)
Australia (8397)
California (14112)
Canada (3940)
China (1527)
Colorado (600)
Connecticut (626)
Delaware (437)
Europe (105130)
Florida (2086)
Georgia (461)
Hawaii (4)
Idaho (68)
Illinois (1196)
India (98)
Indiana (641)
Iowa (24)
Japan (580)
Kansas (141)
Kentucky (54)
Louisiana (48)
Maine (76)
Maryland (1706)
Massachusetts (10251)
Michigan (410)
Minnesota (786)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (29)
Nevada (152)
New Hampshire (92)
New Jersey (3749)
New Mexico (35)
New York (3725)
North Carolina (1865)
North Dakota (11)
Northern California (7061)
Ohio (428)
Oklahoma (26)
Oregon (47)
Pennsylvania (2802)
Puerto Rico (30)
Rhode Island (53)
South America (1415)
South Carolina (87)
South Dakota (2)
Southern California (5573)
Tennessee (223)
Texas (2279)
United States (50297)
Utah (420)
Vermont (1)
Virginia (346)
Washington D.C. (88)
Washington State (1151)
West Virginia (4)
Wisconsin (155)
Wyoming (2)
812,557 Results for "verisante technology inc formerly known as t ray science".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal
After entering the CAR T space in February, Eli Lilly is “jumping into in vivo CAR-T with both feet” with the acquisition of Kelonia Therapeutics and its gene delivery technology.
April 20, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Discure Technologies Appoints Dr. Ray Baker to its Board of Directors
May 5, 2026
·
3 min read
Press Releases
Ray Therapeutics Expands Board Expertise with Appointment of Vikas Sinha, MBA as Director and Chair of the Audit Committee
May 21, 2026
·
3 min read
Press Releases
/C O R R E C T I O N -- Anixa Biosciences, Inc./
May 11, 2026
·
6 min read
Press Releases
/U P D A T E -- Nuvation Bio Inc./
April 22, 2026
·
14 min read
Press Releases
Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions
April 15, 2026
·
6 min read
Job Trends
Washington’s life sciences jobs continue increasing, up 50% from 2014-2024: report
While life sciences employment was down 0.3% nationally in 2024, it rose 1.9% in Washington, according to a new Life Science Washington report. The association’s CEO discusses the latest findings and how the state’s job market looks this year.
April 23, 2026
·
3 min read
·
Angela Gabriel
Press Releases
Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference
April 29, 2026
·
8 min read
Verisante Technology, Inc. Announces 2023 AGM Results
Verisante Technology, Inc. is pleased to announce that at the 2023 Annual General Meeting held on December 18, 2023, in Vancouver, British Columbia, the Company’s shareholders voted in favour of all items of business.
December 20, 2023
·
1 min read
Press Releases
Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute – A Major Milestone for More Efficient and Safer Cancer Treatments
May 27, 2026
·
2 min read
1 of 81,256
Next
